brain shuttle C3 inhibitors (Apellis Pharmacueticals)

N/A

Report date: 2025/03/14 16:29:48

Base Information

Drug Namebrain shuttle C3 inhibitors (Apellis Pharmacueticals)
Drug Alias Namenext generation brain-active C3 inhibitors (Apellis Pharmaceuticals)
ClassificationBiologics
Mechanisms of ActionComplement C3 inhibitors
TargetsComplement C3
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApellis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesApellis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A